Teclistamab offers hope for patients exhausting treatment options
Category: News
New vaccine aims to protect older adults from severe flu complications
Real-world studies show effectiveness of mogamulizumab in routine practice
AviadoBio to receive up to £1.8 billion in potential payments
Biotech company moves forward with phase 2 trial for precision cancer surgery
Scottish Medicines Consortium recommends pembrolizumab
Phase 1 trial of IRL757 demonstrates good absorption and safety profile
Largest real-world study demonstrates significant survival advantage
ISM001-055 shows promise in improving lung function among patients